Skip to main content
Year archive

Vivo Bio tech Ltd. — 2023 filings

All 46 regulatory filings released by Vivo Bio tech Ltd. (511509) in 2023, sourced directly from the official regulator.

46 Filings
2023 Period
2023 filings (46)
Filing Released Lang
Please find enclosed the trading window closure notice in respect of qtr ending 31st December, 2023.
Regulatory Filings
2023-12-30 English
Vivo Bio Tech Limited has infirmed the exchange about the resignation of Ms. Jyotika Aasat as the Company Secretary and Compliance Officer of the Company w.e.f. January 02, 2024
Regulatory Filings
2023-12-23 English
Vivo Bio Tech Limited has submitted with the exchange the copies of Newspaper Publication for Un-Audited Financial Results of the Company for the secodn quarter and half-year ended September 30, 2023
Regulatory Filings
2023-11-16 English
Vivo Bio Tech Limited has submitted with the exchange the Un-Audited Financial Results of the Company for the second quarter and half year ended September 30, 2023
Regulatory Filings
2023-11-14 English
Vivo Bio Tech Limited has informed the exchange about the Outcome of Board Meeting for Approval Of Un-Audited Standalone & Consolidated Financial Statements Of The Company For The Second ....
Regulatory Filings
2023-11-14 English
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the Un-Audited Financial Results ....
Regulatory Filings
2023-11-03 English
Vivo Bio Tech Limited has submitted with the exchange the certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2023
Regulatory Filings
2023-10-13 English
Vivo Bio Tech Limited has informed the exchange about the Appointment of Mr. Shyam Sunder Tipparajau as an Independent Director of the Company as approved by the shareholders in the 36th ....
Regulatory Filings
2023-10-03 English
Vivo Bio Tech Limited has submitted with the exchange the Scrutinizers Report and Voting Reults for business transacted at the 36th Annual General Meeting of the Company held on September 30, 2023.
Regulatory Filings
2023-10-03 English
Vivo Bio Tech Limited has submitted with the exchange the Proceedings of the 36th Annual General Meeting of the Company held on Saturday, Septemebr 30, 2023 at 03.00 p.m.
Regulatory Filings
2023-09-30 English
Vivo Bio Tech Limited has informed the exchange that, the Trading Window for dealing in securities of the Company shall remain closed for all insiders including Designated Persons and their ....
Regulatory Filings
2023-09-29 English
Vivo Bio Tech Limited has informed the exchange that with reference to the Company''s letter dated September 17, 2023, the Board of Directors of the Company at their meeting held today, ....
Regulatory Filings
2023-09-21 English
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2023 ,inter alia, to consider and approve VIVO BIO TECH LTD.has informed ....
Regulatory Filings
2023-09-17 English
Vivo Bio Tech Limited has submitted with the exchange the Newspaper Advertisement for Notice of 36th Annual General Meeting of the Company
Regulatory Filings
2023-09-09 English
Vivo Bio Tech Limited has submitted with the exchange the Notice convening the 36th Annual General Meeting (AGM) of the members of the Company
Regulatory Filings
2023-09-08 English
Vivo Bio Tech Limited has submitted with the exchange the Annual Report of the Company for the financial year 2022-2023.
Regulatory Filings
2023-09-08 English
Vivo Bio Tech Limited has submitted with the exchange, the copies of Newspaper Publication for intimation on convening of 36th Annual General Meeting of the Company and Updating/Registering ....
Regulatory Filings
2023-09-02 English
Vivo Bio Tech Limited has submitted with the exchange, the copies of Newspaper Publication for intimation on convening of 36th Annual General Meeting of the Company and Updating/Registering ....
Regulatory Filings
2023-09-02 English
Vivo Bio Tech Limited has informed the exchange regarding the Book Closure for the purpose of 36th Annual General Meeting of the Company
Regulatory Filings
2023-08-31 English
Vivo Bio Tech Limited has informed the exchange that Mr. Shyam Sunder Tipparaju was appointed as an Additional Director designated as Non-Executive and Independent Director on the Board of the Company
Regulatory Filings
2023-08-31 English
Vivo Bio Tech Limited has informed the exchange regarding the resignation of Mr. Hariharan Ravindran as an Independent Director of the Compamy w.e.f. August 31, 2023.
Regulatory Filings
2023-08-31 English
Vivo Bio Tech Limited has informed the exchange regarding the business items transacted and approved by the Board at its meeting held today i.e. on August 31, 2023
Regulatory Filings
2023-08-31 English
Vivo Bio Tech Limited has submitted with the exchange the copies of newspaper advertisement for publication of Un-Audited Financial Results of the Company for the quarter ended June 30, 2023.
Regulatory Filings
2023-08-09 English
Vivo Bio Tech Limited has submitted with the exchange the Un-Audited Standalone & Consolidated Financial Results for the quarter ended June 30, 2023
Regulatory Filings
2023-08-07 English
Vivo Bio Tech Limited has submitted with the exchange the outcome of Board Meeting held on August 07, 2023 for Approval of Un-Audited Standalone & Consolidated Financial Statements Of The ....
Regulatory Filings
2023-08-07 English
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve Un-Audited Standalone and Consolidated ....
Regulatory Filings
2023-07-24 English
Vivo Bio Tech Limited has submitted with the exchange the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the period from 01.04.2023 to 30.06.2023.
Regulatory Filings
2023-07-10 English
Vivo Bio Tech Limited has informed the exchange that the Trading Window of the Company will be closed for all insiders including designated persons and their immediate relatives from July ....
Regulatory Filings
2023-06-29 English
Vivo Bio Tech Limited has submitted with the exchange the copies of advertisement issued in newspapers on June 01, 2023, in 'Financial Express' in English Language and in 'Nava Telangana' ....
Regulatory Filings
2023-06-01 English
Vivo Bio Tech Limited has submitted with the exchange Related Party Transactions for the half-year period from 01.10.2022 to 31.03.2023
Regulatory Filings
2023-05-30 English
Vivo Bio Tech Limited has submitted with the exchange the Audited Standalone & Consolidated Financial Statements of the Company for the fourth quarter and year ended March 31, 2023.
Regulatory Filings
2023-05-30 English
Vivo Bio Tech Limited has submitted with the exchange the Outcome of Board meeting for the item transacted for approval of Audited Standalone & Consolidated Financial Statements of the ....
Regulatory Filings
2023-05-30 English
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Audited Standalone and Consolidated ....
Regulatory Filings
2023-05-18 English
Vivo Bio Tech Limited has submitted with the Exchange Annual Secretarial Compliance Report for the year ended March 31, 2023.
Regulatory Filings
2023-05-16 English
Vivo Bio Tech Limited has submitted with the exchange the certificate issued by Company Secretary in Practice under Regulation 40(9) read with Regulation 40 (10) of the SEBI (Listing Obligations ....
Regulatory Filings
2023-04-26 English
Vivo Bio Tech Limited has submitted with the exchange the Compliance Certificate for the year ended March 31, 2023 in complinace with Regulation 7(3) of SEBI (Listing Obligations and Disclosure ....
Regulatory Filings
2023-04-18 English
Vivo Bio Tech Limited has submitted with the exchange the certificate received from M/s. Aarthi Consultants Private Limited (Registrar and Share Transfer Agent), for the period from January ....
Regulatory Filings
2023-04-14 English
Vivo Bio Tech Limited has submitted with the exchange the Clarification on Price Movement in connection with email received from BSE on April 10, 2023.
Regulatory Filings
2023-04-11 English
Vivo Bio Tech Limited has informed the exchange that, Mr. Sunder Kanaparthy (DIN: 00914869), Independent Director has resigned from the Board of Directors w.e.f April 01, 2023 due to his ....
Regulatory Filings
2023-03-31 English
Vivo Bio Tech Limited has informed the exchange that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Company's Internal Code of Conduct to Regulate, Monitor and Report ....
Regulatory Filings
2023-03-31 English
Vivo Bio Tech Limited has submitted with the exchange the copies of advertisement issued in newspapers on February 15, 2023, in ''Financial Express'' in English Language and in ''Nava Telangana'' ....
Regulatory Filings
2023-02-15 English
Vivo Bio Tech Limited has submitted with the exchange the Un-Audited Standalone & Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022.
Regulatory Filings
2023-02-13 English
Vivo Bio Tech Limited has submitted with the exchange the Outcome of Board meeting for the item transacted for apporval of Un-Audited Standalone & Consolidated Financial Results for the ....
Regulatory Filings
2023-02-13 English
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve the Un-Audited Standalone & ....
Regulatory Filings
2023-01-30 English
Vivo Bio Tech Limited has submitted with the exchange the certificate received from M/s. Aarthi Consultants Private Limited (Registrar and Share Transfer Agent), for the period from October ....
Regulatory Filings
2023-01-10 English
Vivo Bio Tech Limited has informed the exchange that the Company has today allotted 27,000 Equity Shares under Vivo Bio Employees Stock Option Scheme, 2016 to the eligible employees of ....
Regulatory Filings
2023-01-04 English